drugset / Trial / NCT04202211
FMT for Remission of Active Ulcerative Colitis in Adults
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study is to establish the safety and effectiveness of lyophilized (LYO) fecal microbiota transplant (FMT) for treating ulcerative colitis (UC) in adults. The protocol is being re-designed to address relevant, current research questions in the context of FMT treatment for UC. Once a final protocol is approved, this webpage will be updated.
Timeline
- Start
- 2022-03
- Primary completion
- 2024-12
- Completion
- 2028-12
Outcome
Outcome not reported
Stopped: “Protocol changed substantially enough to warrant a separate submission”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | FMT | Unknown | 1 unknown | Oral |
| Comparator | FMT | Unknown | 1 unknown | Oral |
| Comparator | FMT | Unknown | 10 unknown | Oral |
| Comparator | FMT | Unknown | 10 unknown | Oral |